Revisions for Atovaquone

Revisions allow you to track differences between multiple versions of your content, and revert back to older versions.

RevisionOperations
02-13-25 by ripal121current revision
02-7-25 by ripal121

ripal121 replaced Intermittent HD assumes high-flux hemodialysis. CRRT assumes CVVHD with ultrafiltration rate 2L/h and residual native GFR with Intermittent HD assumes high-flux hemodialysis. CRRT assumes CVVHD with ultrafiltration rate 2L/h and residual native GFR < 10 mL/min. via Scanner Search and Replace module.

02-7-25 by ripal121

ripal121 replaced Intermittent HD with Intermittent HD assumes high-flux hemodialysis. CRRT assumes CVVHD with ultrafiltration rate 2L/h and residual native GFR < 10 mL/min. via Scanner Search and Replace module.

02-7-25 by conan.macdougal...

conan.macdougall@ucsf.edu replaced For detailed view of dialysis dosing and evidence, see <a href="https://idmp.ucsfsitebuilder.acsitefactory.com/content/ucsf-adult-antimicrobial-dosing-dialysis-reference-document">Dosing in Hemodialysis</a> document.</p> with via Scanner Search and Replace module.

02-4-25 by ripal121
11-26-24 by ripal121
11-26-24 by ripal121
11-25-24 by ripal121

Dosing: Adult Antimicrobial Dosing, Non-dialysis

Indication Dose  Notes 
Pneumocystis PROPHYLAXIS 1500 mg PO Q24H with food  For patients who are intolerant of TMP-SMX
Pneumocystis TREATMENT (mild disease) 750 mg PO Q12H with food 

For patients who are intolerant of TMP-SMX 

Mild disease (A-a O2 gradient < 35 mmHg and PAO2 >70 mmHg)

Dosing: Antimicrobial Dosing in Intermittent & Continuous Hemodialysis

Indication Dose  Notes 
Pneumocystis PROPHYLAXIS 1500 mg PO Q24H with food  For patients who are intolerant of TMP-SMX
Pneumocystis TREATMENT (mild disease)  750 mg PO Q12H with food 

For patients who are intolerant of TMP-SMX

Mild disease  (A-a O2 gradient < 35 mmHg and PAO2 >70 mmHg)

Dialysis Notes

References: